id: unnecessary_interventions_to_healthcare_costs
name: Unnecessary and Ineffective Pharmacological and Interventional Therapy â†’ Healthcare
  Costs
from_node:
  node_id: unnecessary_interventions
  node_name: Unnecessary and Ineffective Pharmacological and Interventional Therapy
to_node:
  node_id: healthcare_costs
  node_name: Healthcare Costs
direction: positive
category: economic
mechanism_pathway:
- 'Step 1: Lack of effective authorized therapies leads to use of unproven or ineffective
  interventions'
- 'Step 2: Pharmacological and procedural interventions without evidence base are
  administered'
- 'Step 3: These unnecessary interventions incur substantial direct medical costs'
- 'Step 4: Financial burden increases without corresponding improvement in clinical
  outcomes'
evidence:
  quality_rating: C
  n_studies: 1
  primary_citation: Cyriac Abby Philips 2024. "A comprehensive review of diagnosis
    and management of alcohol-associated hepatitis.." *SAGE open medicine*. https://doi.org/10.1177/20503121241297000
last_updated: '2025-12-02'
version: '1.0'
llm_metadata:
  extracted_by: claude-sonnet-4-5-20250929
  extraction_date: '2025-12-02T18:12:05.388372'
  batch_id: msgbatch_01AKnPJgzm7Fk9qubgAz9GaD
moderators:
- name: evidence_based_guidelines
  direction: weakens
  strength: moderate
  description: Implementation of evidence-based guidelines can reduce use of ineffective
    therapies and associated costs
- name: fee_for_service_payment
  direction: strengthens
  strength: moderate
  description: Payment systems that reimburse for procedures regardless of effectiveness
    may incentivize unnecessary interventions
